E-LIB Suche - Ergebnisse für: Prince, H.Miles

1

Breast Implant Associated Anaplastic Large Cell Lymphoma: E..:

Clemens, Mark W. ; Myckatyn, Terence ; Di Napoli, Arianna...
Plastic & Reconstructive Surgery. , 2024

Link: https://doi.org/10.1097/..

2

Long‐term survival and safety of elranatamab in patients wi..:

Tomasson, Michael H. ; Iida, Shinsuke ; Niesvizky, Ruben...
HemaSphere. 8 (2024) 7 - p. , 2024

Link: https://doi.org/10.1002/..

3

Improving disease‐specific survival for patients with Sezar..:

Campbell, Belinda A. ; Dobos, Gabor ; Haider, Zahra...
British Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

4

Isatuximab-pomalidomide-dexamethasone versus pomalidomide-d..:

Richardson, Paul G. ; Perrot, Aurore ; Miguel, Jesus San...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

5

MM-364 Elranatamab, a B-Cell Maturation Antigen (BCMA)-CD3 ..:

Mohty, Mohamad ; Tomasson, Michael H. ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S493-S494 , 2023

Link: https://doi.org/10.1016/..

6

The importance of frailty assessment in multiple myeloma: a..:

Sim, Shirlene ; Kalff, Anna ; Tuch, Gina...
Internal Medicine Journal. 53 (2023) 5 - p. 819-824 , 2023

Link: https://doi.org/10.1111/..

7

Executive summary of consensus clinical practice guidelines..:

Teh, Benjamin W. ; Reynolds, Gemma ; Slavin, Monica A....
Internal Medicine Journal. , 2023

Link: https://doi.org/10.1111/..

8

P-307 Efficacy and safety of elranatamab monotherapy in pat..:

Raab, Marc ; Manier, Salomon ; Prince, H. Miles...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S207-S208 , 2023

Link: https://doi.org/10.1016/..

9

POSTER: MM-364 Elranatamab, a B-Cell Maturation Antigen (BC..:

Mohty, Mohamad ; Tomasson, Michael H. ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S225 , 2023

Link: https://doi.org/10.1016/..

10

International study of treatment efficacy in SS shows super..:

Campbell, Belinda A. ; Dobos, Gabor ; Haider, Zahra...
Blood Advances. 7 (2023) 21 - p. 6639-6647 , 2023

Link: https://doi.org/10.1182/..

11

CD30‐positive lymphoproliferative disorders—An Australian C..:

Bhabha, Friyana K. ; McCormack, Christopher ; Campbell, Belinda A....
Australasian Journal of Dermatology. 64 (2023) 2 - p. 194-203 , 2023

Link: https://doi.org/10.1111/..

12

Elranatamab in relapsed or refractory multiple myeloma: pha..:

Lesokhin, Alexander M. ; Tomasson, Michael H. ; Arnulf, Bertrand...
Nature Medicine. 29 (2023) 9 - p. 2259-2267 , 2023

Link: https://doi.org/10.1038/..

13

P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DI..:

Walewski, Jan ; Min Kim, Tae ; Cho, Seok-Goo...
HemaSphere. 7 (2023) S3 - p. e50570ac , 2023

Link: https://doi.org/10.1097/..

14

A Population-Based Family Case–Control Study of Sun Exposur..:

Odutola, Michael K. ; van Leeuwen, Marina T. ; Bruinsma, Fiona...
Cancer Epidemiology, Biomarkers & Prevention. 33 (2023) 1 - p. 106-116 , 2023

Link: https://doi.org/10.1158/..

15

P-306 Final results of a Phase 1b study of subcutaneous isa..:

Quach, Hang ; Parmar, Gurdeep ; Ocio, Enrique...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S206-S207 , 2023

Link: https://doi.org/10.1016/..